Andrew Hughes
Director/Board Member at CellCentric Ltd.
Profile
Andrew Hughes is currently a Non-Executive Director at CellCentric Ltd.
and a Strategy Director at Manchester Cancer Research Centre.
Previously, he worked as the Chairman of Translational Medicine at The University of Manchester, an Independent Director at PCI Biotech Holding ASA, and the Worldwide Clinical Head of Early Phase Oncology at AstraZeneca AS.
Andrew Hughes active positions
| Companies | Position | Start |
|---|---|---|
| Manchester Cancer Research Centre | Corporate Officer/Principal | - |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2022-04-05 |
Former positions of Andrew Hughes
| Companies | Position | End |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Director/Board Member | 2023-05-24 |
| The University of Manchester | Corporate Officer/Principal | - |
| AstraZeneca AS | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| Private companies | 3 |
|---|---|
| AstraZeneca AS | |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Manchester Cancer Research Centre |
- Stock Market
- Insiders
- Andrew Hughes
